🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tick-borne Encephalitis (TBE) can be prevented by vaccine. Vaccine failure,...
Status
Unknown
Location
Region Örebro Län
Start Date
2024-01
Trial ID
NCT04573205
Treatments Being Tested
The purpose of this study is to assess the seropersistence of TBE antibodie...
Status
Completed
Location
Grieskirchner Strasse 17
Start Date
2005-05
Trial ID
NCT00161967
Treatments Being Tested
The objective of this study is to establish the earliest time point at whic...
Status
Completed
Location
SGS Biopharma Research Unit Stuivenberg
Start Date
2004-03
Trial ID
NCT00161954
Treatments Being Tested
The purpose of this study is to assess: * TBE antibody persistence 24, 34,...
Status
Completed
Location
Hospital in Debica - Zespol Opieki Zdrowotnej w Debicy
Start Date
2007-07
Trial ID
NCT00503529
Treatments Being Tested
The purpose of this study is to evaluate TBE antibody persistence from 7 to...
Status
Completed
Location
Prywatny Gabinet Lekarski
Start Date
2012-04
Trial ID
NCT01582698
Treatments Being Tested
The main purpose of this study is to assess the seropersistence of TBE viru...
Status
Completed
Location
Grieskirchnerstr.17
Start Date
2009-04-26
Trial ID
NCT00894686
Allergic patients especially those undergoing de-sensitization treatment ha...
Status
Completed
Location
Medical University Vienna, Institute of Specific Prophylaxis and Tropical Medicine
Start Date
2013-09
Trial ID
NCT02511535
Treatments Being Tested
The purpose of this study is to assess: * TBE antibody persistence 2 and 3...
Status
Completed
Location
Hospital in Debica - Zespo Opieki Zdrowotnej w Debicy
Start Date
2004-06
Trial ID
NCT00161785
Treatments Being Tested
The study aims to answer this question: whether adequate immunity can be ac...
Status
Unknown
Location
Elisabethinen Hospital
Start Date
2007-03
Trial ID
NCT00890422
Treatments Being Tested
The objective of this study is to investigate the immunogenicity and safety...
Status
Completed
Location
SGS Biopharma Research Unit Stuivenberg
Start Date
2005-05
Trial ID
NCT00163540
Treatments Being Tested